News

  • 9 October 2011

    FDA approves Ventana H. pylori antibody

    Ventana Medical Systems, a member of the Roche Group, has secured 510(k) clearance from the Food and Drug Administration (FDA) for its Helicobacter pylori antibody.

  • 9 October 2011

    Positive trial results for Brainsway deep TMS system

    Brainsway has reported additional interim results of a clinical trial being conducted at the Ichilov Medical Center in Israel to evaluate the efficacy of a deep transcranial magnetic stimulation (TMS)...

  • 9 October 2011

    Bioness completes foot drop study enrolment phase

    Bioness has completed the initial enrolment phase of the FASTEST study to further examine the affect of its Ness L300 wireless neurostimulation technology on individuals with foot drop.

  • 9 October 2011

    Carticept’s Navigator DS gets FDA clearance

    The US Food and Drug Administration (FDA) has granted 510(k) approval for Carticept Medicals' Navigator Delivery System (Navigator DS) to treat cartilage injuries and osteoarthritis.

  • 6 October 2011

    Abbott enrols first patient in EXCEL trial

    Abbott has enrolled its first patient in the evaluation of XIENCE PRIME/XIENCE V versus coronary artery bypass surgery for the effectiveness of left main eervascularization (EXCEL) trial.

  • 6 October 2011

    Illumina joins UNTHSC for forensic DNA analysis

    Illumina has entered into a collaborative research agreement with the Department of Forensic and Investigative Genetics and the Institute of Applied Genetics at the University of North Texas Health Science...

Close
Close
Close

Go Top